Published in Anesth Analg on March 04, 2013
Multivesicular liposomal bupivacaine at the sciatic nerve. Biomaterials (2014) 0.88
Perineural dexamethasone to improve postoperative analgesia with peripheral nerve blocks: a meta-analysis of randomized controlled trials. Pain Res Treat (2014) 0.84
From micro- to nanostructured implantable device for local anesthetic delivery. Int J Nanomedicine (2016) 0.75
Attenuation of Experimental Autoimmune Neuritis with Locally Administered Lovastatin-Encapsulating PLGA Nanoparticles. J Neurochem (2016) 0.75
Tetrodotoxin, Epinephrine, and Chemical Permeation Enhancer Combinations in Peripheral Nerve Blockade. Anesth Analg (2017) 0.75
Drug delivery systems for prolonged duration local anesthesia. Mater Today (Kidlington) (2016) 0.75
Destruction and regeneration of skeletal muscle after treatment with a local anaesthetic, bupivacaine (Marcaine). J Anat (1970) 2.03
Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum (2011) 1.88
Neurologic evaluation of the rat during sciatic nerve block with lidocaine. Anesthesiology (1995) 1.57
Myotoxicity of local anesthetics and regeneration of the damaged muscle fibers. Anesth Analg (1980) 1.49
A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther (2011) 1.49
Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid. Biomaterials (2004) 1.47
Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres. Anesthesiology (1996) 1.37
Prolonged intercostal nerve blockade in sheep using controlled-release of bupivacaine and dexamethasone from polymer microspheres. Anesthesiology (1998) 1.36
A comparison of the neurotoxic effects on the spinal cord of tetracaine, lidocaine, bupivacaine, and ropivacaine administered intrathecally in rabbits. Anesth Analg (2003) 1.28
A re-examination of tetrodotoxin for prolonged duration local anesthesia. Anesthesiology (1998) 1.21
Prolonged duration local anesthesia with minimal toxicity. Proc Natl Acad Sci U S A (2009) 1.21
Tetrodotoxin for prolonged local anesthesia with minimal myotoxicity. Muscle Nerve (2006) 1.14
Local myotoxicity from sustained release of bupivacaine from microparticles. Anesthesiology (2008) 1.11
Effect of procaine, carbocain and xylocaine on cutaneous muscle in rabbits and mice. Acta Anaesthesiol Scand (1959) 1.11
Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres. Pain (2003) 1.10
Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium. J Biomed Mater Res (2002) 1.10
Prolonged regional nerve blockade by controlled release of local anesthetic from a biodegradable polymer matrix. Anesthesiology (1993) 1.06
Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology (1996) 1.03
Local myotoxicity of bupivacaine in rabbits after continuous supraclavicular brachial plexus block. Reg Anesth (1994) 1.01
Liposphere local anesthetic timed-release for perineural site application. Pharm Res (1998) 1.00
The Safety of EXPAREL ® (Bupivacaine Liposome Injectable Suspension) Administered by Peripheral Nerve Block in Rabbits and Dogs. J Drug Deliv (2012) 0.99
Pharmacokinetic Compatibility Study of Lidocaine with EXPAREL in Yucatan Miniature Pigs. ISRN Pharm (2011) 0.96
Tissue injury from tricyclic antidepressants used as local anesthetics. Anesth Analg (2005) 0.95
Comparison of myotoxic effects of lidocaine with epinephrine in rats and humans. Anesth Analg (1981) 0.95
Sciatic nerve blockade with lipid-protein-sugar particles containing bupivacaine. Pharm Res (2000) 0.93
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone. J Biomed Mater Res A (2005) 0.93
Local anesthetic myotoxicity: a case and review. Anesthesiology (1994) 0.92
Neurotoxicity of local anesthetics: animal data. Reg Anesth (1994) 0.91
An absorbable local anesthetic matrix provides several days of functional sciatic nerve blockade. Anesth Analg (2009) 0.90
Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison. J Drug Deliv (2011) 0.89
Injectable, mixed natural-synthetic polymer hydrogels with modular properties. Biomacromolecules (2012) 0.88
The safety and tolerability evaluation of DepoFoam bupivacaine (bupivacaine extended-release liposome injection) administered by incision wound infiltration in rabbits and dogs. Expert Opin Investig Drugs (2011) 0.88
Bupivacaine causes cytotoxicity in mouse C2C12 myoblast cells: involvement of ERK and Akt signaling pathways. Acta Pharmacol Sin (2010) 0.86
The relationship between functional sciatic nerve block duration and the rate of release of lidocaine from a controlled-release matrix. Anesth Analg (2010) 0.85
Effect of excipient composition on the biocompatibility of bupivacaine-containing microparticles at the sciatic nerve. J Biomed Mater Res A (2004) 0.85
[Complications and adverse events in continuous peripheral regional anesthesia Results of investigations on 3,491 catheters]. Anaesthesist (2006) 0.84
Injectable microparticle-gel system for prolonged and localized lidocaine release. II. In vivo anesthetic effects. J Biomed Mater Res A (2004) 0.83
Ultra-long-duration local anesthesia produced by injection of lecithin-coated tetracaine microcrystals. J Clin Pharmacol (1994) 0.83
[Cardiotoxic and neurotoxic effects after accidental intravascular bupivacaine administration. Therapy with lidocaine propofol and lipid emulsion]. Anaesthesist (2007) 0.83
Liposomal bupivacaine. Extended duration nerve blockade using large unilamellar vesicles that exhibit a proton gradient. Anesthesiology (1996) 0.83
Lipid-sugar particles for intracranial drug delivery: safety and biocompatibility. Brain Res (2002) 0.81
Prolonged analgesia with liposomal bupivacaine in a mouse model. Reg Anesth (1994) 0.81
Some effects of local anesthetic agents on skeletal muscle. Exp Neurol (1972) 0.81
Liposomal formulations of prilocaine: effect of complexation with hydroxypropyl-ß-cyclodextrin on drug anesthetic efficacy. J Liposome Res (2010) 0.80
Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine. Chem Pharm Bull (Tokyo) (1982) 0.80
Spray-dryed bupivacaine-loaded microspheres: in vitro evaluation and biopharmaceutics of bupivacaine following brachial plexus administration in sheep. Int J Pharm (2002) 0.79
Prolongation of intrathecal and sciatic nerve blocks using a complex of levobupivacaine with maltosyl-beta-cyclodextrin in rats. Anesth Analg (2007) 0.77
Time course of mitochondrial metabolism alterations to repeated injections of bupivacaine in rat muscle. Can J Anaesth (2010) 0.77
Rheological blends for drug delivery. I. Characterization in vitro. J Biomed Mater Res A (2010) 0.77
Complex of branched cyclodextrin and lidocaine prolonged the duration of peripheral nerve block. J Anesth (2009) 0.76
Analysis of the acute cytotoxic potential of bupivacaine and 50% enantiomeric excess bupivacaine (s75-r25) incorporated into microspheres in rat sciatic nerves. Rev Bras Anestesiol (2012) 0.76
Engineering vascularized skeletal muscle tissue. Nat Biotechnol (2005) 7.73
Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol (2010) 3.15
Macroporous nanowire nanoelectronic scaffolds for synthetic tissues. Nat Mater (2012) 2.57
The excess morbidity and mortality of emergency general surgery. J Trauma Acute Care Surg (2015) 2.08
A magnetically triggered composite membrane for on-demand drug delivery. Nano Lett (2009) 1.77
Nanowired three-dimensional cardiac patches. Nat Nanotechnol (2011) 1.76
Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Mol Pharm (2009) 1.61
Hyaluronic acid-based microgels and microgel networks for vocal fold regeneration. Biomacromolecules (2006) 1.61
Remotely triggerable drug delivery systems. Adv Mater (2010) 1.60
Micromolding of photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures. Biomaterials (2006) 1.54
The biocompatibility of mesoporous silicates. Biomaterials (2008) 1.50
Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid. Biomaterials (2004) 1.47
Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery. Small (2009) 1.41
Magnetically triggered nanocomposite membranes: a versatile platform for triggered drug release. Nano Lett (2011) 1.31
In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model. Biomaterials (2006) 1.27
Photoswitchable nanoparticles for triggered tissue penetration and drug delivery. J Am Chem Soc (2012) 1.22
Prolonged duration local anesthesia with minimal toxicity. Proc Natl Acad Sci U S A (2009) 1.21
Near-infrared-actuated devices for remotely controlled drug delivery. Proc Natl Acad Sci U S A (2014) 1.16
Tetrodotoxin for prolonged local anesthesia with minimal myotoxicity. Muscle Nerve (2006) 1.14
Local myotoxicity from sustained release of bupivacaine from microparticles. Anesthesiology (2008) 1.11
A drug-eluting contact lens. Invest Ophthalmol Vis Sci (2009) 1.08
Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit repeated-injury model. Biomaterials (2007) 1.08
Combinatorial extracellular matrices for human embryonic stem cell differentiation in 3D. Biomacromolecules (2010) 1.08
Photocrosslinkable hydrogel for myocyte cell culture and injection. J Biomed Mater Res B Appl Biomater (2007) 1.06
A microcomposite hydrogel for repeated on-demand ultrasound-triggered drug delivery. Biomaterials (2010) 1.05
Prevention of peritoneal adhesions with an in situ cross-linkable hyaluronan hydrogel delivering budesonide. J Control Release (2007) 1.04
Nanoparticles targeting the infarcted heart. Nano Lett (2011) 1.03
Synthetic ligand-coated magnetic nanoparticles for microfluidic bacterial separation from blood. Nano Lett (2013) 1.02
The prevention of peritoneal adhesions by in situ cross-linking hydrogels of hyaluronic acid and cellulose derivatives. Biomaterials (2006) 1.01
Injectable in situ cross-linking hydrogels for local antifungal therapy. Biomaterials (2009) 1.01
Photo-targeted nanoparticles. Nano Lett (2010) 1.00
pH-triggered microparticles for peptide vaccination. J Immunol (2004) 1.00
Photoswitchable nanoparticles for in vivo cancer chemotherapy. Proc Natl Acad Sci U S A (2013) 0.99
In situ cross-linkable hyaluronan hydrogels containing polymeric nanoparticles for preventing postsurgical adhesions. Ann Surg (2007) 0.99
Dextran-based in situ cross-linked injectable hydrogels to prevent peritoneal adhesions. Biomaterials (2007) 0.98
Shedding light on nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2012) 0.97
Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation. Am J Respir Crit Care Med (2007) 0.96
Prolonged nerve blockade delays the onset of neuropathic pain. Proc Natl Acad Sci U S A (2012) 0.96
A photolithographic method to create cellular micropatterns. Biomaterials (2006) 0.95
Tissue injury from tricyclic antidepressants used as local anesthetics. Anesth Analg (2005) 0.95
Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone. Biomaterials (2007) 0.95
Prolonged sensory-selective nerve blockade. Proc Natl Acad Sci U S A (2010) 0.94
Antifungal hydrogels. Proc Natl Acad Sci U S A (2007) 0.94
Peritoneal application of chitosan and UV-cross-linkable chitosan. J Biomed Mater Res A (2006) 0.93
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone. J Biomed Mater Res A (2005) 0.93
Enhanced photothermal effect of plasmonic nanoparticles coated with reduced graphene oxide. Nano Lett (2013) 0.91
Site 1 sodium channel blockers prolong the duration of sciatic nerve blockade from tricyclic antidepressants. Pain (2004) 0.91
Polymers in the prevention of peritoneal adhesions. Eur J Pharm Biopharm (2007) 0.90
Effect of chemical permeation enhancers on nerve blockade. Mol Pharm (2009) 0.90
Elasticity and safety of alkoxyethyl cyanoacrylate tissue adhesives. Acta Biomater (2011) 0.89
Contact lenses for drug delivery. Semin Ophthalmol (2009) 0.87
In vivo performance of a drug-eluting contact lens to treat glaucoma for a month. Biomaterials (2013) 0.87
Injectable microparticle-gel system for prolonged and localized lidocaine release. I. In vitro characterization. J Biomed Mater Res A (2004) 0.87
Financial incentive increases CPAP acceptance in patients from low socioeconomic background. PLoS One (2012) 0.87
Microparticulate formulations for the controlled release of interleukin-2. J Pharm Sci (2004) 0.86
Materials to clinical devices: technologies for remotely triggered drug delivery. Clin Ther (2012) 0.86
Electrospun drug-eluting sutures for local anesthesia. J Control Release (2012) 0.85
Complex coacervates for thermally sensitive controlled release of flavor compounds. J Agric Food Chem (2005) 0.85
Hydroxyapatite for keratoprosthesis biointegration. Invest Ophthalmol Vis Sci (2011) 0.85
Effect of excipient composition on the biocompatibility of bupivacaine-containing microparticles at the sciatic nerve. J Biomed Mater Res A (2004) 0.85
Rheological blends for drug delivery. II. Prolongation of nerve blockade, biocompatibility, and in vitro-in vivo correlations. J Biomed Mater Res A (2010) 0.83
Injectable microparticle-gel system for prolonged and localized lidocaine release. II. In vivo anesthetic effects. J Biomed Mater Res A (2004) 0.83
Nanogel scavengers for drugs: local anesthetic uptake by thermoresponsive nanogels. Acta Biomater (2011) 0.82
In vivo evaluation of tetrahedral amorphous carbon. Biomaterials (2005) 0.82
Microdevices for nanomedicine. Mol Pharm (2013) 0.82
Prospects for near-infrared technology in remotely triggered drug delivery. Expert Opin Drug Deliv (2014) 0.82
Duration and local toxicity of sciatic nerve blockade with coinjected site 1 sodium-channel blockers and quaternary lidocaine derivatives. Reg Anesth Pain Med (2012) 0.81
Formulations for trans-tympanic antibiotic delivery. Biomaterials (2012) 0.81
A prototype antifungal contact lens. Invest Ophthalmol Vis Sci (2011) 0.81
Modular 'click-in-emulsion' bone-targeted nanogels. Adv Mater (2012) 0.81
Three-dimensional conductive constructs for nerve regeneration. J Biomed Mater Res A (2009) 0.80
SDF-1α in glycan nanoparticles exhibits full activity and reduces pulmonary hypertension in rats. Biomacromolecules (2013) 0.80
The smartest materials: the future of nanoelectronics in medicine. ACS Nano (2012) 0.80
Nanotechnology for surgeons. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 0.80
Forced-exercise attenuates experimental autoimmune neuritis. Neurochem Int (2012) 0.79
Liposomes for HIV prophylaxis. Biomaterials (2011) 0.79
A Stiff Injectable Biodegradable Elastomer. Adv Funct Mater (2013) 0.79
Prevention of ventilator-induced lung edema by inhalation of nanoparticles releasing ruthenium red. Am J Respir Cell Mol Biol (2014) 0.79
An in situ cross-linking hybrid hydrogel for controlled release of proteins. Acta Biomater (2012) 0.79
Surface modification and drug delivery for biointegration. Ther Deliv (2011) 0.79
Mortality after emergency surgery continues to rise after discharge in the elderly: Predictors of 1-year mortality. J Trauma Acute Care Surg (2015) 0.78
Toxicogenomic analysis of a sustained release local anesthetic delivery system. Biomaterials (2012) 0.78
Thermoresponsive nanogels for prolonged duration local anesthesia. Acta Biomater (2012) 0.78
Topical drug formulations for prolonged corneal anesthesia. Cornea (2013) 0.78
Rheological blends for drug delivery. I. Characterization in vitro. J Biomed Mater Res A (2010) 0.77
Nanocomposite gold-silk nanofibers. Nano Lett (2012) 0.77